You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

XENON XE 127 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Xenon Xe 127 patents expire, and when can generic versions of Xenon Xe 127 launch?

Xenon Xe 127 is a drug marketed by Mallinckrodt and is included in one NDA.

The generic ingredient in XENON XE 127 is xenon xe-127. There are twelve drug master file entries for this compound. Additional details are available on the xenon xe-127 profile page.

Summary for XENON XE 127
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 5
Patent Applications: 119
DailyMed Link:XENON XE 127 at DailyMed
Drug patent expirations by year for XENON XE 127
Anatomical Therapeutic Chemical (ATC) Classes for XENON XE 127

US Patents and Regulatory Information for XENON XE 127

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt XENON XE 127 xenon xe-127 GAS;INHALATION 018536-001 Oct 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mallinckrodt XENON XE 127 xenon xe-127 GAS;INHALATION 018536-002 Oct 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.